Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Lefebvre

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Cancers|December 26, 2018
A New Patient-Derived Metastatic Glioblastoma Cell Line: Characterisation and Response to Sodium Selenite Anticancer AgentSylvie Berthier, Louis Larrouquère, Pierre Champelovier, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2021
Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentationsAmal Fekkar, Camille Emprou, Christine Lefebvre, et al.
Clinical Epigenetics|December 20, 2024
BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomasLoris Delrieu, Sieme Hamaidia, Emilie Montaut, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 26, 2012
Accurate detection of the tumor clone in peripheral T-cell lymphoma biopsies by flow cytometric analysis of TCR-Vβ repertoireDimitri Salameire, Françoise Solly, Blandine Fabre, et al.
Genes, Chromosomes & Cancer|July 23, 2013
BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphomaLeila Rouhigharabaei, Julio Finalet Ferreiro, Natalie Put, et al.
Oncotarget|December 30, 2017
Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromesMathieu Meunier, Sarah Ancelet, Christine Lefebvre, et al.
British Journal of Haematology|May 25, 2026
Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non-Hodgkin lymphomasCoura Fall, Agnès Daudignon, Séverine Valmary-Degano, et al.
BMJ Open|October 7, 2022
Flow cytometry lyophilised-reagent tube for quantifying peripheral blood neutrophil myeloperoxidase expression in myelodysplastic syndromes (MPO-MDS-Develop): protocol for a diagnostic accuracy studyTatiana Raskovalova, Laura Scheffen, Marie-Christine Jacob, et al.
British Journal of Haematology|June 22, 2021
Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copiesLucile Bussot, Simon Chevalier, Justine Cristante, et al.
BMJ Open|August 22, 2025
Flow cytometric lyophilised reagent tube assay for peripheral blood neutrophil myeloperoxidase expression to rule out myelodysplastic neoplasms at a university hospital: a diagnostic accuracy studyCharlotte Planta, Laura Scheffen, Marie-Christine Jacob, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Cancers|December 26, 2018
A New Patient-Derived Metastatic Glioblastoma Cell Line: Characterisation and Response to Sodium Selenite Anticancer AgentSylvie Berthier, Louis Larrouquère, Pierre Champelovier, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2021
Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentationsAmal Fekkar, Camille Emprou, Christine Lefebvre, et al.
Clinical Epigenetics|December 20, 2024
BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomasLoris Delrieu, Sieme Hamaidia, Emilie Montaut, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 26, 2012
Accurate detection of the tumor clone in peripheral T-cell lymphoma biopsies by flow cytometric analysis of TCR-Vβ repertoireDimitri Salameire, Françoise Solly, Blandine Fabre, et al.
Genes, Chromosomes & Cancer|July 23, 2013
BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphomaLeila Rouhigharabaei, Julio Finalet Ferreiro, Natalie Put, et al.
Oncotarget|December 30, 2017
Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromesMathieu Meunier, Sarah Ancelet, Christine Lefebvre, et al.
British Journal of Haematology|May 25, 2026
Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non-Hodgkin lymphomasCoura Fall, Agnès Daudignon, Séverine Valmary-Degano, et al.
BMJ Open|October 7, 2022
Flow cytometry lyophilised-reagent tube for quantifying peripheral blood neutrophil myeloperoxidase expression in myelodysplastic syndromes (MPO-MDS-Develop): protocol for a diagnostic accuracy studyTatiana Raskovalova, Laura Scheffen, Marie-Christine Jacob, et al.
British Journal of Haematology|June 22, 2021
Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copiesLucile Bussot, Simon Chevalier, Justine Cristante, et al.
BMJ Open|August 22, 2025
Flow cytometric lyophilised reagent tube assay for peripheral blood neutrophil myeloperoxidase expression to rule out myelodysplastic neoplasms at a university hospital: a diagnostic accuracy studyCharlotte Planta, Laura Scheffen, Marie-Christine Jacob, et al.
Pageof 9